Keywords: celera, acquire, atria, genetics, 33m, deal, enter
Celera to acquire Atria Genetics in $33M deal to enter HLA market
Article | 01 October 2007
Maryland, USA-based Celera, an Applera Corp business, and South San Francisco-headquartered Atria Genetics, a privately-held company, have signed a definitive ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
